Ariel E. Birnbaum MD
Assistant Professor, Medicine, Brown University Program in Medicine
Join to View Full Profile
593 Eddy StProvidence, RI 02903
Phone+1 401-444-5391
Fax+1 401-444-8918
Dr. Birnbaum is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Rhode Island Hospital/Brown University HealthFellowship, Hematology and Medical Oncology, 2003 - 2006
University of MinnesotaResidency, Internal Medicine, 1994 - 1997
The University of Toledo College of MedicineClass of 1994
Certifications & Licensure
RI State Medical License 2004 - 2028
MN State Medical License 1997 - 2003
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Cloverleaf Integration Suite, Infor (US), Inc., 2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2017
Publications & Presentations
PubMed
- Fianlimab, a human lymphocyte activation gene-3 monoclonal antibody, in combination with cemiplimab: Tumor-specific expansion cohorts in advanced malignancies.Tae Min Kim, Stephen K Williamson, Kyriakos P Papadopoulos, Omid Hamid, Grace K Dy
Cancer. 2026-05-01 - 6 citationsMethylation cytometric pretreatment blood immune profiles with tumor mutation burden as prognostic indicators for survival outcomes in head and neck cancer patients on...Ze Zhang, Kartik Sehgal, Keisuke Shirai, Rondi A Butler, John K Wiencke
NPJ Precision Oncology. 2024-11-18 - 117 citationsDual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial.Charu Aggarwal, Amy Prawira, Scott Antonia, Osama Rahma, Anthony Tolcher
Journal for Immunotherapy of Cancer. 2022-04-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
